disease progression

Numares to Develop Multi-biomarker Test of SPMS Transition

Numares has signed an exclusive licensing agreement with Oxford University Innovation to develop and commercialize a panel of biomarkers that identify disease progression in people with multiple sclerosis (MS). Specifically, the company aims to create a tool that detects early signs of conversion from relapsing remitting…

Nurse With MS Wins Grant to Find Severity, Progression Biomarkers

A nurse and PhD candidate with multiple sclerosis (MS) is looking for disease biomarkers that can help healthcare providers better estimate how individual cases of MS will progress. The goal of Stephanie Buxhoeveden’s research, now supported by a grant from the American Association of Nurse Practitioners (AANP), is…

Nerve Tissue Scarring May Explain MS Progression

Nerve tissue scars associated with multiple sclerosis (MS) show marked differences from those of similar neurodegenerative disorders, according to a recent study. MS-associated inflammation causes brain and spinal cord lesions (nerve tissue scarring) that often are bigger and last longer than those of two other demyelinating diseases: myelin oligodendrocyte…

Retinal Layer Thickness May Predict MS Progression, Relapses

Measurements of the thickness of the eye’s retina ā€” the layer of nerve cells lining the back of the eye ā€” could be used to predict disability progression and relapses in people with multiple sclerosis (MS), a real-world study from Austria suggests. ā€œOur study shows that both crossectional and…

Enrollment Complete in Phase 2 Trial Testing Temelimab

GeNeuroĀ has completed patient enrollment in its ProTEct-MS Phase 2 clinical trial evaluating temelimab as a treatment for multiple sclerosis (MS), the company announced. The study (NCT04480307), taking place at the Karolinska Institutetā€™s Academic Specialist Center (ASC) in Stockholm, Sweden, has enrolled 42 people with relapsing MS whose…

Early-life Trauma Affects MS Development, Treatment in Mice

Childhood trauma can affect disease progression of multiple sclerosis (MS) and treatment in adulthood, a study in mice suggests. The study shows that mice that experienced early-life trauma were more likely to develop an autoimmune condition and less likely to respond to common treatment with interferon beta. The study,…

Brain Changes in Relapsing MS Found to Follow Pattern

Changes in the amount of grey matter in specific regions of the brain appear to occur early in relapsing multiple sclerosis (MS), while structural changes in white matter happen late in disease progression. These were among the findings of a recent study that tracked the sequence of events in…

Immune Cellsā€™ Ability to Clear Myelin Debris Is Potential Therapeutic Approach for MS, Mouse Study Shows

Oral administration ofĀ trehaloseĀ ā€” a sugar molecule found in plants and fungi and reported to have neuroprotective effects ā€” eased symptoms and halted disease progression in a mouse model ofĀ multiple sclerosisĀ (MS). These benefits were associated with a restoration of the ability ofĀ microgliaĀ (the brainā€™s immune cells) to break down…